While many sexually transmitted infections (STIs) dominate public discourse, Trichomoniasis remains oddly under the radar—despite affecting nearly 300 million people globally every year. But behind the scenes, the Trichomoniasis Drug Market is quietly accelerating, backed by growing awareness, better diagnostics, and a rising demand for faster, more effective...